Patents by Inventor David Scholl

David Scholl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250095849
    Abstract: Systems and methods for managing patient diagnostic and therapy workflows in a hospital and/or radiology centers. A radiology recommendation agent is trained using reinforcement learning and a simulation environment in which the agent takes actions and receives feedback from the simulation environment based on how its action affect the simulation environment over time.
    Type: Application
    Filed: February 27, 2024
    Publication date: March 20, 2025
    Inventors: Vivek Singh, Ankur Kapoor, Ingo Schmuecking, Scott Steingall, David Scholl, Dorin Comaniciu
  • Patent number: 9797901
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays. Such improvements are based upon the superior performance of assays comprising a chimeric TSH receptor in the presence of a glucocorticoid including, but not limited to, dexamethasone.
    Type: Grant
    Filed: October 14, 2013
    Date of Patent: October 24, 2017
    Assignee: Diagnostics Hybrid, Inc.
    Inventors: Leonard Kohn, Jim Brown, David Scholl, Yunsheng Li, Giorgio Napolitano
  • Publication number: 20140120552
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays. Such improvements are based upon the superior performance of assays comprising a chimeric TSH receptor in the presence of a glucocorticoid including, but not limited to, dexamethasone.
    Type: Application
    Filed: October 14, 2013
    Publication date: May 1, 2014
    Applicant: QUIDEL CORPORATION
    Inventors: LEONARD KOHN, JIM BROWN, DAVID SCHOLL, YUNSHENG LI, GIORGIO NAPOLITANO
  • Patent number: 8563257
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays. Such improvements are based upon the superior performance of assays comprising a chimeric TSH receptor in the presence of a glucocorticoid including, but not limited to, dexamethasone.
    Type: Grant
    Filed: June 12, 2009
    Date of Patent: October 22, 2013
    Assignee: Diagnostic Hybrids, Inc.
    Inventors: Leonard Kohn, Jim Brown, David Scholl, Yunsheng Li, Giorgio Napolitano
  • Publication number: 20110305715
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to 3-hydroxycotinine (3HC). The invention also provides compositions containing these antibodies and fragments thereof, and to their use in diagnostic and therapeutic applications for diseases involving nicotine activity (e.g., smoking and/or smokeless tobacco use).
    Type: Application
    Filed: June 10, 2011
    Publication date: December 15, 2011
    Inventors: Lynn Y. Miao, Jennifer G. Johnson, Adriana Navarro, Paul Olivo, David Scholl
  • Publication number: 20090325177
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays. Such improvements are based upon the superior performance of assays comprising a chimeric TSH receptor in the presence of a glucocorticoid including, but not limited to, dexamethasone.
    Type: Application
    Filed: June 12, 2009
    Publication date: December 31, 2009
    Inventors: Leonard Kohn, Jim Brown, David Scholl, Yunsheng Li, Giorgio Napolitano
  • Publication number: 20060286667
    Abstract: The present invention generally relates to the field of diagnostic microbiology, and, more particularly; to compositions and methods for detecting and differentiating one or more viruses or other intracellular parasites present in a specimen. The present invention also provides compositions and methods to evaluate the susceptibility of organisms to antimicrobial agents.
    Type: Application
    Filed: April 28, 2006
    Publication date: December 21, 2006
    Applicants: Diagnostic Hybrids, Inc., University Hospitals of Cleveland
    Inventors: David Scholl, Yung Huang, Patricia Goodrum
  • Publication number: 20050095582
    Abstract: The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus.
    Type: Application
    Filed: November 3, 2003
    Publication date: May 5, 2005
    Applicants: Diagnostic Hybrids, Inc., Health Research Incorporated
    Inventors: Laura Gillim-Ross, Jill Taylor, David Scholl, David Wentworth, Joseph Jollick
  • Publication number: 20050074221
    Abstract: A vision system (10) for a vehicle (14) includes a light source (46) that generates an illumination beam (20). A receiver (62) generates a first image signal and a second image signal. The first image signal is generated in response to a reflected portion of the illumination beam (20). A controller is coupled to the light source (46) and the receiver (62). The controller generates an image in response to the first image signal and the second image signal.
    Type: Application
    Filed: October 6, 2003
    Publication date: April 7, 2005
    Inventors: Jeffrey Remillard, Kenneth Nietering, Willes Weber, David Scholl, Michael Marinelli
  • Patent number: 6850836
    Abstract: A method for assessing noise generated during combustion in an internal combustion engine, such method comprising determining a noise index by processing a signal generated in a cylinder of such engine in accordance with a shift invariant wavelet transform.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: February 1, 2005
    Assignee: Ford Global Technologies, LLC
    Inventors: David Scholl, Urs Christen